TREM1 and atherosclerosis: In the Trem-1−/−-Apoe−/− model, TREM-1 deficiency significantly mitigates atherosclerosis by reducing monocytosis, inflammatory plaque formation, and expression of chemokine receptors like CX3CR1 on nonclassical monocytes.